三個皮匠報告
政策庫
new
付費
搜索

全球DLL3/CD3抗體進度（部分產品梳理）-行業數據

全球DLL3/CD3抗體進度（部分產品梳理）
全球DLL3/CD3抗體進度（部分產品梳理）
● DLL3/CD3 雙特異性 T 細胞銜接器目前正處于治療小細胞肺癌 (SCLC) 和其他神經內分泌癌 (NEC) 的 II 期試驗階段。中國生物制藥在臨床進展中名列第二位。
其它 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?73KB 圖片尺寸：2333*1339
同報告圖片
 / 49
全球DLL3/CD3抗體進度（部分產品梳理）_第1頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第2頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第3頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第4頁
fCDogrrnmYzvvIjkuK3lm73vvIkgICAgICAgICB8IDIwMjQgICAgfCAyMDI1ICAgIHwgMjAyNiAgICB8IDIwMjcgICAgfCAyMDI4ICAgIHwgMjAyOSAgICB8IDIwMzAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS18Cnwg5paw5Y+R5Lq65pWw77yI5Lq677yJICAgICAgIHwgMSwxMzIsNTM5IHwgMSwxNjksMzUwIHwgMSwyMDYsMTYwIHwgMSwyNDIsOTcwIHwgMSwyNzksNzgwIHwgMSwzMTYsNTkxIHwgMSwzNTMsNDAxIHwKfCDmlrDlj5HkurrmlbDvvIjkuIfkurrvvIkgICAgIHwgMTEzLjI1ICB8IDExNi45NCAgfCAxMjAuNjIgIHwgMTI0LjMwICB8IDEyNy45OCAgfCAxMzEuNjYgIHwgMTM1LjM0ICB8Cnwg5bCP57uG6IOe6IK655mM77yI5LiH5Lq677yJICAgfCAxNi45OSAgIHwgMTcuNTQgICB8IDE4LjA5ICAgfCAxOC42NCAgIHwgMTkuMjAgICB8IDE5Ljc1ICAgfCAyMC4zMCAgIHwKfCDlub/ms5vmnJ/lsI/nu4bog57ogrrnmYzvvIjkuIfkurrvvIkgfCAxMS4zOCAgIHwgMTEuNzUgICB8IDEyLjEyICAgfCAxMi40OSAgIHwgMTIuODYgICB8IDEzLjIzICAgfCAxMy42MCAgIHwKfCDlsYDpmZDmnJ/lsI/nu4bog57ogrrnmYzvvIjkuIfkurrvvIkgfCA1LjYxICAgIHwgNS43OSAgICB8IDUuOTcgICAgfCA2LjE1ICAgIHwgNi4zMyAgICB8IDYuNTIgICAgfCA2LjcwICAgIHwKfCDkuqflk4HluILljaDnjocoJSkgICAgICAgIHwgMC41MCUgICB8IDIuMDAlICAgfCA1LjAwJSAgIHwgOC4wMCUgICB8IDEwLjAwJSAgfCA4LjAwJSAgIHwgOC4wMCUgICB8Cnwg5rK755aX5bm06LS555So77yI5LiH5YWD77yJICAgfCAyOC4zOCAgIHwgMTcuMDMgICB8IDE1LjMzICAgfCAxMy43OSAgIHwgMTIuNDEgICB8IDExLjE3ICAgfCAxMC4wNSAgIHwKfCDplIDllK7pop3vvIjkur/lhYPvvIkgICAgICAgfCAxLjYyICAgIHwgNC4wMCAgICB8IDkuMjkgICAgfCAxMy43OCAgIHwgMTUuOTcgICB8IDExLjgzICAgfCAxMC45NCAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOWFqOeQg+WlveiNr+i1hOiur++8jOaWueato+ivgeWIuOeglOeptuaJgA==
全球DLL3/CD3抗體進度（部分產品梳理）_第5頁
全球DLL3/CD3抗體進度（部分產品梳理）_第6頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第7頁
全球DLL3/CD3抗體進度（部分產品梳理）_第8頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第9頁
全球DLL3/CD3抗體進度（部分產品梳理）_第10頁
全球DLL3/CD3抗體進度（部分產品梳理）_第11頁
全球DLL3/CD3抗體進度（部分產品梳理）_第12頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第13頁
全球DLL3/CD3抗體進度（部分產品梳理）_第14頁
全球DLL3/CD3抗體進度（部分產品梳理）_第15頁
全球DLL3/CD3抗體進度（部分產品梳理）_第16頁
fCBUaW1lIHNpbmNlIHJhbmRvbWl6YXRpb24gKG1vbnRoKSB8IENyaXpvdGluaWIgfCBFbnZub2xha2liIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTMzICAgICAgICB8IDEzMSAgICAgICAgfAp8IDIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEyOCAgICAgICAgfCAxMjMgICAgICAgIHwKfCA0ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMTIgICAgICAgIHwgMTE2ICAgICAgICB8CnwgNiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgOTUgICAgICAgICB8IDEwNyAgICAgICAgfAp8IDggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDc2ICAgICAgICAgfCA5OSAgICAgICAgIHwKfCAxMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2OCAgICAgICAgIHwgODggICAgICAgICB8CnwgMTIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNTMgICAgICAgICB8IDcwICAgICAgICAgfAp8IDE0ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDQyICAgICAgICAgfCA2NSAgICAgICAgIHwKfCAxNiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAzOSAgICAgICAgIHwgNTkgICAgICAgICB8CnwgMTggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMzYgICAgICAgICB8IDU4ICAgICAgICAgfAp8IDIwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDM1ICAgICAgICAgfCA1NCAgICAgICAgIHwKfCAyMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAzMSAgICAgICAgIHwgNTQgICAgICAgICB8CnwgMjQgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMjYgICAgICAgICB8IDQ4ICAgICAgICAgfAp8IDI2ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDIwICAgICAgICAgfCA0MSAgICAgICAgIHwKfCAyOCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxNSAgICAgICAgIHwgMzEgICAgICAgICB8CnwgMzAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEgICAgICAgICB8IDIyICAgICAgICAgfAp8IDMyICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwICAgICAgICAgfCAxMCAgICAgICAgIHwKfCAzNCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAyICAgICAgICAgIHwgMSAgICAgICAgICB8CnwgMzYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICB8IDEgICAgICAgICAgfAp8IDM4ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgfCAwICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muaZtOWMu+iNn++8jOaWueato+ivgeWIuOeglOeptuaJgA==
全球DLL3/CD3抗體進度（部分產品梳理）_第17頁
全球DLL3/CD3抗體進度（部分產品梳理）_第18頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第19頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第20頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第21頁
全球DLL3/CD3抗體進度（部分產品梳理）_第22頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第23頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第24頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第25頁
fCDlubTku70gfCDkuK3lm71OQVNI5biC5Zy66KeE5qih77yI5Lq/5YWD77yJIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE2IHwgNSAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE3IHwgNiAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE4IHwgNiAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE5IHwgNyAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIwIHwgNyAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIxRSB8IDggICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMkUgfCA5ICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjNFIHwgMTEgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI0RSB8IDE2ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNUUgfCAzMiAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjZFIHwgNjEgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI3RSB8IDEwOSAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyOEUgfCAxNzQgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjlFIHwgMjUzICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDMwRSB8IDM1NSAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpGREEgbmV3c++8jOWMu+iNr+mAn+iniO+8jOaWueato+ivgeWIuOeglOeptuaJgA==
全球DLL3/CD3抗體進度（部分產品梳理）_第26頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第27頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第28頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第29頁
全球DLL3/CD3抗體進度（部分產品梳理）_第30頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第31頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第32頁
全球DLL3/CD3抗體進度（部分產品梳理）_第33頁
全球DLL3/CD3抗體進度（部分產品梳理）_第34頁
全球DLL3/CD3抗體進度（部分產品梳理）_第35頁
全球DLL3/CD3抗體進度（部分產品梳理）_第36頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第37頁
全球DLL3/CD3抗體進度（部分產品梳理）_第38頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第39頁
fCDoja/lk4HlkI3np7AgICAgICAgICAgICAgICAgICAgICB8IOeUs+ivt+exu+WeiyB8IOazqOWGjOWIhuexuyB8IOaJv+WKnuaXpeacnyAgICB8IOWkp+exuyAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18Cnwg5aWl6LSd6IOG6YW454mHICAgICAgICAgICAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDMg57G7IHwgMjAyNC8yLzEgICAgfCDmtojljJbns7vnu5/lj4rku6PosKLoja8gfAp8IOazqOWwhOeUqOmGi+mFuOWcsOWKoOeRnuWFiyAgICAgICAgICAgfCDnlLPor7fnlJ/kuqcgfCDku7/liLYgNCDnsbsgfCAyMDI0LzEvMjQgICB8IOaKl+iCv+eYpOWSjOWFjeeWq+iwg+iKguWJgiB8Cnwg5aGe5omY5rq06ZO15ZC45YWl57KJ6Zu+5YmCICAgICAgICAgICB8IOeUs+ivt+S4tOW6iiB8IOS7v+WItiA0IOexuyB8IDIwMjMvMTIvMTUgIHwg5ZG85ZC457O757uf55So6I2vICAgICB8Cnwg6YaL6YW46Zi/5q+U54m56b6Z54mHKElJKSAgICAgICAgICAgfCDnlLPor7fkuLTluoogfCDku7/liLYgMyDnsbsgfCAyMDIzLzEyLzE0ICB8IOaKl+iCv+eYpOWSjOWFjeeWq+iwg+iKguWJgiB8Cnwg5rKZ5qC85YiX5rGA5LqM55Sy5Y+M6ION57yT6YeK54mHKElJSSkgICB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiA0IOexuyB8IDIwMjMvMTAvMjUgIHwg5raI5YyW57O757uf5Y+K5Luj6LCi6I2vICB8Cnwg5rKZ5qC85YiX5rGA5LqM55Sy5Y+M6ION57yT6YeK54mHKEkpICAgICB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiA0IOexuyB8IDIwMjMvMTAvMjUgIHwg5raI5YyW57O757uf5Y+K5Luj6LCi6I2vICB8Cnwg5a+M6ams6YW45LyP6K+65ouJ55Sf54mHICAgICAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMy8xMC8yNSAgfCDmtojljJbns7vnu5/lj4rku6PosKLoja8gIHwKfCDms6jlsITnlKjlpLTlraLku5bllbbpmL/nu7Tlt7TlnabpkqAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMy8xMC84ICAgfCDlhajouqvnlKjmipfmhJ/mn5Poja/niakgIHwKfCDms6jlsITnlKjntKvmnYnphoco55m96JuL55m957uT5ZCI5Z6LKSAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMy84LzI0ICAgfCDmipfogr/nmKTlkozlhY3nlqvosIPoioLliYIgfAp8IOeUsuejuumFuOiJvuaXpeW4g+ael+azqOWwhOa2siAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMy84LzIyICAgfCDmipfogr/nmKTlkozlhY3nlqvosIPoioLliYIgfAp8IOihgOeuoee0p+W8oOe0oCBJSSDms6jlsITmtrIgICAgICAgICB8IOeUs+ivt+S4tOW6iiB8IOS7v+WItiAzIOexuyB8IDIwMjMvOC8xNyAgIHwg5b+D6ISR6KGA566h57O757uf6I2v54mpICB8Cnwg6Im+5Zyw6aqo5YyW6YaH6L2v6IO25ZuKICAgICAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMy84LzE3ICAgfCDmtojljJbns7vnu5/lj4rku6PosKLoja8gIHwKfCDmganmm7Lku5bmu6jkuJnphZrmm7/or7rnpo/pn6bniYcoSUkpICAgfCDnlLPor7fnlJ/kuqcgfCDku7/liLYgNCDnsbsgfCAyMDIzLzcvMjggICB8IOWFqOi6q+eUqOaKl+aEn+afk+iNr+eJqSAgfAp8IOWliOaLiea7qOazqOWwhOa2siAgICAgICAgICAgICAgICAgfCDnlLPor7fkuLTluoogfCDku7/liLYgMyDnsbsgfCAyMDIzLzcvMTMgICB8IOaKl+iCv+eYpOWSjOWFjeeWq+iwg+iKguWJgiB8Cnwg5q+U5Y2h6bKB6IO654mHICAgICAgICAgICAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMi85LzIyICAgfCDmipfogr/nmKTlkozlhY3nlqvosIPoioLliYIgfAp8IOmShueJuemGh+azqOWwhOa2siAgICAgICAgICAgICAgICAgfCDnlLPor7fnlJ/kuqcgfCDku7/liLYgNCDnsbsgfCAyMDIyLzYvMjAgICB8IOadguexuyAgICAgICAgICAgfAp8IOeimOaZrue9l+iDuuazqOWwhOa2siAgICAgICAgICAgICAgIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDQg57G7IHwgMjAyMi80LzI4ICAgfCDmnYLnsbsgICAgICAgICAgIHwKfCDphZLnn7PphbjpmL/npo/nvZfnvZfpm77ljJblkLjlhaXmurbmtrIgICB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiAzIOexuyB8IDIwMTkvMTEvMjkgIHwg5ZG85ZC457O757uf55So6I2vICAgICB8Cnwg5Y+z5YWw57Si5ouJ5ZSR6IKg5rq26IO25ZuKICAgICAgICAgICB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiAzIOexuyB8IDIwMTgvOC8xNCAgIHwg5raI5YyW57O757uf5Y+K5Luj6LCi6I2vICB8Cnwg5LmM576O5rq06ZO157u05YWw54m5572X57KJ5ZC45YWl5YmCICAgICB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiA0IOexuyB8IDIwMTgvNy8yMCAgIHwg5ZG85ZC457O757uf55So6I2vICAgICB8Cnwg57Og6YW45rCf5pu/5Y2h5p2+57u05YWw54m5572X57KJ6Zu+5YmCKElJKSB8IOeUs+ivt+eUn+S6pyB8IOS7v+WItiAzIOexuyB8IDIwMTgvNy8yMCAgIHwg5ZG85ZC457O757uf55So6I2vICAgICB8Cnwg57Og6YW45rCf5pu/5Y2h5p2+57u05YWw54m5572X57KJ6Zu+5YmCKEkpIHwg55Sz6K+355Sf5LqnIHwg5Lu/5Yi2IDMg57G7IHwgMjAxOC83LzIwICAgfCDlkbzlkLjns7vnu5/nlKjoja8gICAgIHwKCui1hOaWmeadpea6kO+8muexs+WGhee9ke+8jOaWueato+ivgeWIuOeglOeptuaJgA==
全球DLL3/CD3抗體進度（部分產品梳理）_第40頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第41頁
全球DLL3/CD3抗體進度（部分產品梳理）_第42頁
全球DLL3/CD3抗體進度（部分產品梳理）_第43頁
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
全球DLL3/CD3抗體進度（部分產品梳理）_第44頁
全球DLL3/CD3抗體進度（部分產品梳理）_第45頁
全球DLL3/CD3抗體進度（部分產品梳理）_第46頁
全球DLL3/CD3抗體進度（部分產品梳理）_第47頁
全球DLL3/CD3抗體進度（部分產品梳理）_第48頁
全球DLL3/CD3抗體進度（部分產品梳理）_第49頁
全球DLL3/CD3抗體進度（部分產品梳理）_第50頁
所屬報告： 中國生物制藥-港股公司深度報告：全面轉型創新進入收獲期BD&MA+國際化打開全新戰略空間-240708（44頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站